Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 551 to 600 of 1898

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyTA725
Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancerTA724
Bimekizumab for treating moderate to severe plaque psoriasisTA723
Pemigatinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangementTA722
Magnetic resonance therapy for knee osteoarthritisIPG702
Laparoscopic removal of uterine fibroids with power morcellationIPG703
Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroidsIPG704
Babies, children and young people's experience of healthcareNG204
Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndromeTA139
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16sNG202
Antenatal careNG201
Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphomaTA720
Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancerTA721
Bronchiolitis in children: diagnosis and managementNG9
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA716
Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhageIPG701
Clostridioides difficile infection: antimicrobial prescribingNG199
Duvelisib for treating relapsed follicular lymphoma after 2 or more systemic therapies (terminated appraisal)TA717
Ixekizumab for treating axial spondyloarthritisTA718
Secukinumab for treating non-radiographic axial spondyloarthritisTA719
ENDURALIFE powered CRT-D devices for treating heart failureMTG33
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal)TA714
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failedTA715
Enzalutamide for treating hormone-sensitive metastatic prostate cancerTA712
Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapyTA713
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillationTA249
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillationTA256
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA355
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA275
Atrial fibrillation: diagnosis and managementNG196
Plus Sutures for preventing surgical site infectionMTG59
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitisTA708
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA709
Ravulizumab for treating atypical haemolytic uraemic syndromeTA710
Laser lithotripsy for difficult-to-treat bile duct stonesIPG699
Percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valveIPG700
Patient experience in adult NHS services: improving the experience of care for people using adult NHS servicesCG138
Shared decision makingNG197
Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancerTA707
Autism spectrum disorder in adults: diagnosis and managementCG142
Autism spectrum disorder in under 19s: support and managementCG170
Ozanimod for treating relapsing–remitting multiple sclerosisTA706
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancerTA705
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)TA702
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)TA703
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Electrohydraulic lithotripsy for difficult-to-treat bile duct stonesIPG698
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplantIPG695
Transvaginal laser therapy for stress urinary incontinenceIPG696
Transvaginal laser therapy for urogenital atrophyIPG697

Results per page

  1. 10
  2. 25
  3. 50
  4. All